Biotage AB (publ) (OTCMKTS:BITGF) Sees Large Growth in Short Interest

Biotage AB (publ) (OTCMKTS:BITGFGet Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 13,800 shares, an increase of 146.4% from the April 15th total of 5,600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

BITGF has been the subject of several recent analyst reports. Berenberg Bank reduced their target price on Biotage AB (publ) from SEK 293 to SEK 263 in a research report on Friday, April 22nd. Nordea Equity Research upgraded Biotage AB (publ) from a “hold” rating to a “buy” rating in a research report on Monday, March 14th. SEB Equities lowered Biotage AB (publ) from a “buy” rating to a “hold” rating and set a SEK 236 price target for the company. in a research note on Friday, April 22nd. Danske raised Biotage AB (publ) from a “hold” rating to a “buy” rating in a research note on Monday, February 14th. Finally, SEB Equity Research lowered Biotage AB (publ) to a “hold” rating and set a $236.00 target price for the company. in a research note on Friday, April 22nd. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Biotage AB (publ) presently has an average rating of “Buy” and a consensus price target of $245.00.

OTCMKTS BITGF opened at $16.50 on Friday. Biotage AB has a 1-year low of $16.50 and a 1-year high of $31.08. The stock has a 50-day moving average of $17.52 and a 200-day moving average of $23.63.

About Biotage AB (publ) (Get Rating)

Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts.

Featured Articles

Receive News & Ratings for Biotage AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotage AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.